z-logo
open-access-imgOpen Access
Reduction in Myocardial Ischemia/Reperfusion Injury in Group X Secretory Phospholipase A 2 –Deficient Mice
Author(s) -
Daisuke Fujioka,
Yukio Saitō,
Tsuyoshi Kobayashi,
Toshiaki Yano,
Hiroyasu Tezuka,
Yoshikazu Ishimoto,
Noriko Suzuki,
Yusuke Yokota,
Takamitsu Nakamura,
Jyun-ei Obata,
Masato Kanazawa,
Ken−ichi Kawabata,
Kohji Hanasaki,
Kiyotaka Kugiyama
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.743997
Subject(s) - arachidonic acid , medicine , phospholipase a2 , ischemia , phospholipase , platelet , pharmacology , myeloperoxidase , phospholipase a , reperfusion injury , endocrinology , biochemistry , inflammation , enzyme , biology
Background— Group X secretory phospholipase A2 (sPLA2 -X) has the most potent hydrolyzing activity toward phosphatidylcholine and elicits a marked release of arachidonic acid among several types of sPLA2 . sPLA2 -X is expressed in neutrophils, but its pathogenic role remains unclear.Methods and Results— We generated mice that lack sPLA2 -X and studied their response to myocardial ischemia/reperfusion. The sPLA2 -X−/− mice had a significant reduction in myocardial infarct size and a decrease in myocardial myeloperoxidase activity compared with sPLA2 -X+/+ mice. Myocardial infarct size was also significantly reduced in lethally irradiated sPLA2 -X+/+ mice reconstituted with sPLA2 -X−/− bone marrow compared with sPLA2 -X+/+ bone marrow. The extent of myocardial ischemia/reperfusion injury was comparable between sPLA2 -X−/− and sPLA2 -X+/+ mice in Langendorff experiments using isolated hearts and blood-free perfusion buffer, supporting a potential role of sPLA2 -X in blood in myocardial ischemia/reperfusion injury. In the infarcted myocardium of sPLA2 -X+/+ mice, sPLA2 -X was released from neutrophils but not myocardial tissues and platelets and was undetectable in the peripheral serum. The sPLA2 -X−/− mice had lower accumulation of neutrophils in ischemic myocardium, and the isolated sPLA2 -X−/− neutrophils had lower release of arachidonic acid and attenuated cytotoxic activities including respiratory burst compared with sPLA2 -X+/+ neutrophils. The attenuated functions of sPLA2 -X−/− neutrophils were reversible by the exogenous addition of sPLA2 -X protein. Furthermore, administration of a sPLA2 inhibitor reduced myocardial infarct size and suppressed the cytotoxic activity of sPLA2 -X+/+ neutrophils.Conclusions— Myocardial ischemia/reperfusion injury was attenuated in sPLA2 -X−/− mice partly through the suppression of neutrophil cytotoxic activities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here